"Racially-tailored" medicine unraveled.
Hoffman
Sharona
S
Law-Medicine Center, Case Western Reserve University School of Law, USA.
D002317:Cardiovascular Agents / Q000494:pharmacology / Q000627:therapeutic use; D002961:Civil Rights / Q000331:legislation & jurisprudence; D003695:Delivery of Health Care; D004338:Drug Combinations; D028744:Ethics Committees, Research; D035082:Federal Government; D005380:Financing, Government; D036281:Genetic Research / Q000331:legislation & jurisprudence; D006333:Heart Failure / Q000188:drug therapy / Q000208:ethnology; D006801:Humans; D006830:Hydralazine / Q000494:pharmacology / Q000627:therapeutic use; D007548:Isosorbide Dinitrate / Q000494:pharmacology / Q000627:therapeutic use; D009316:National Institutes of Health (U.S.); D016134:Organizational Policy; D028701:Patient Rights / Q000331:legislation & jurisprudence; D010597:Pharmacogenetics / Q000941:ethics; D011287:Prejudice; D044469:Racial Groups / Q000235:genetics*; D013219:State Government; D014481:United States
D002317:Cardiovascular Agents; D004338:Drug Combinations; D006830:Hydralazine; D007548:Isosorbide Dinitrate